CN Stock MarketDetailed Quotes

R&G PharmaStudies (301333)

Watchlist

58.17
-0.53-0.90%

Noon Break May 15 11:30 CST

5.62BMarket Cap42.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

R&G PharmaStudies (301333) Key Financial Indicators

301333 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of R&G PharmaStudies shows that the company's current ratio is 6.01, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

301333 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of R&G PharmaStudies, the quick ratio is 5.86, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

301333 Return on Equity (ROE)

Want to learn more about the financial health of R&G PharmaStudies? The latest ROE figure is 1.15%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

301333 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of R&G PharmaStudies, the total asset return on investment (ROA) is 0.95%.

Currency: CNY

Cumulative Quarterly

301333 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check R&G PharmaStudies's latest financial report to see how their gross margin is doing - currently at 30.19%.

Currency: CNY

Cumulative Quarterly

301333 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of R&G PharmaStudies, the net profit margin is 10.49%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm